000 01186 a2200349 4500
005 20250515165322.0
264 0 _c20090512
008 200905s 0 0 eng d
022 _a0264-410X
024 7 _a10.1016/j.vaccine.2009.02.008
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGiezeman, K M
245 0 0 _aTrivalent inactivated subunit influenza vaccine Influvac: 25-Year experience of safety and immunogenicity.
_h[electronic resource]
260 _bVaccine
_cApr 2009
300 _a2414-7 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAntibodies, Viral
_xblood
650 0 4 _aHumans
650 0 4 _aInfluenza Vaccines
_xadverse effects
650 0 4 _aMiddle Aged
650 0 4 _aRandomized Controlled Trials as Topic
650 0 4 _aVaccines, Inactivated
_xadverse effects
650 0 4 _aVaccines, Subunit
_xadverse effects
700 1 _aNauta, J
700 1 _ade Bruijn, I A
700 1 _aPalache, A M
773 0 _tVaccine
_gvol. 27
_gno. 18
_gp. 2414-7
856 4 0 _uhttps://doi.org/10.1016/j.vaccine.2009.02.008
_zAvailable from publisher's website
999 _c18800824
_d18800824